QT Vascular clinches key patent in Singapore

The product also has regulatory clearance in Japan and China.

Catalist-listed QT Vascular, a developer and manufacturer of medical devices for the treatment of vascular diseases, yesterday revealed that the Singapore patent office has granted TriReme Medical LLC, its wholly owned US subsidiary, Singapore patent number 184930 for a “balloon catheter with improved column strength and torque”.

GliderXtreme PTA is part of TriReme Medical’s Glider family of PTA and PTCA products which incorporate the combined features of a torque-able shaft and a skived tip. GliderXtreme PTA has an additional unique design feature, called “slide-lock”, which provides for a low profile (<4F) shaft with double the column strength compared to a conventional PTA balloon catheter. 

GliderXtreme PTA balloon catheter already has regulatory clearance in Japan and China. Along with the Glider PTCA balloon catheter, sales of GliderXtreme PTA in Asia are expected to add to company growth in the region in 2015.